Wiley HE, Srinivasan R, Maranchie JK, Chhablani J, et al. Oral HIF-2alpha Inhibitor Belzutifan in Ocular von Hippel-Lindau Disease: Subgroup Analysis of the Single-Arm Phase 2 LITESPARK-004 Study. Ophthalmology 2024 Jun 5:S0161-6420(24)00319.
PMID: 38849055